Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy

April 5, 2024 updated by: Chul Ho Chang, Gangnam Severance Hospital

Application of Individualized Positive End-expiratory Pressure Using Electrical Impedance Tomography (EIT) in Patients Undergoing Robot Assisted Laparoscopic Prostatectomy : a Randomized Controlled Study

Steep trendelenburg posture or pneumoperitoneum for surgery causes ventilation problems during surgery, so finding a way to overcome is a challenging task for anesthesiologists. In this study, for patients undergoing robot assisted laparoscopic prostatectomy under general anesthesia, anesthesia is going to perform by applying conventional positive end-expiratory pressure (PEEP 5cmH2O) or individually determined positive end-expiratory pressure values for each patient using electrical impedance tomography. We plan to compare intraoperative ventilation through arterial blood gas analysis to find out the way to improve intraoperative ventilation.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, Korea, Republic of
        • Recruiting
        • Gangnam Severacne Hospital Yonsei University College of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 20 - 70 years of age who are scheduled for robotic assisted laparoscopic prostatectomy at the Department of Urology, Gangnam Severance Hospital,
  2. ASA-PS (American Society of Anesthesiology Body Rating) I-IlI,
  3. Patients with a BMI of 35 kg/m2 or less

Exclusion Criteria:

  1. Patients with lung disease
  2. BMI >35kg/m2
  3. Patients for whom positive end-tidal pressure cannot be applied (large bullae, severe cardiac disease)
  4. patient refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: conventional PEEP
Apply of PEEP 5
Maintain positive end expiratory pressure at 5 cmH2O throughout the surgery.
Active Comparator: optimized PEEP
Apply of optimized PEEP derived using EIT (airtom®)
Immediately after induction of anesthesia, the patient remains unapplied to PEEP. After pneumoperitoneum + Trendelenburg posture, an appropriate PEEP value is derived using electrical impedance tomography (airtom®). And then derived value ( = optimized PEEP value) is applied until the end of the operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PaO2/FiO2
Time Frame: end of surgery (before extubation)
PaO2/FiO2 is the ratio of arterial oxygen partial pressure (PaO2) to oxygen fraction (FiO2), and is a commonly used indicator for evaluating pulmonary ventilation and diagnosing lung damage. Using this index, it is possible to determine whether oxygen obtained through the lungs is well delivered to the blood or not. It can be easily obtained by arterial blood gas analysis without complicated formulas or graphs.
end of surgery (before extubation)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PaO2/FiO2
Time Frame: 15 minutes after intubation, 1 hour after pnemoperitoneum
partial pressure (PaO2) to oxygen fraction (FiO2), and is a commonly used indicator for evaluating pulmonary ventilation and diagnosing lung damage. Using this index, it is possible to determine whether oxygen obtained through the lungs is well delivered to the blood or not. It can be easily obtained by arterial blood gas analysis without complicated formulas or graphs.
15 minutes after intubation, 1 hour after pnemoperitoneum
ROI (region of interests)
Time Frame: 15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
region of interest using EIT
15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
inhomogeneity index
Time Frame: 15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
inhomogeneity index : this index calculated from tidal EIT images representing the difference in impedance between the end of inspiration and the end of expiration.
15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
total amount of fluid administered during surgery
Time Frame: end or surgery
end or surgery
total dose of vasopressor administered during surgery
Time Frame: end of surgery
end of surgery
length of hospitalization after surgery
Time Frame: 1 month after surgery
1 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2023

Primary Completion (Estimated)

November 10, 2024

Study Completion (Estimated)

November 10, 2024

Study Registration Dates

First Submitted

December 9, 2022

First Submitted That Met QC Criteria

December 21, 2022

First Posted (Actual)

December 30, 2022

Study Record Updates

Last Update Posted (Actual)

April 8, 2024

Last Update Submitted That Met QC Criteria

April 5, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prostate Cancer

Clinical Trials on conventional PEEP

Subscribe